Résultats de la recherche - Gibson, Michael
- Résultat(s) 1 - 20 résultats de 46
- Aller à la page suivante
-
1
-
2
Acute Urography par Roylance, John, Gibson, Michael J., Davies, Peter
Publié 1969Texte -
3
-
4
-
5
-
6
-
7
-
8
-
9
Atrial Conduction Slows Immediately Before the Onset of Human Atrial Fibrillation: A Bi-Atrial Contact Mapping Study of Transitions to Atrial Fibrillation par Lalani, Gautam G., Schricker, Amir, Gibson, Michael, Rostamian, Armand, Krummen, David E., Narayan, Sanjiv M.
Publié 2012Texte -
10
Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes par Gomez-Casal, Roberto, Bhattacharya, Chitralekha, Ganesh, Nandita, Bailey, Lisa, Basse, Per, Gibson, Michael, Epperly, Michael, Levina, Vera
Publié 2013Texte -
11
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes par Xu, Xu Steven, Moore, Kenneth, Burton, Paul, Stuyckens, Kim, Mueck, Wolfgang, Rossenu, Stefaan, Plotnikov, Alexei, Gibson, Michael, Vermeulen, An
Publié 2012Texte -
12
A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcino... par Zahoor, Haris, Luketich, James D., Levy, Ryan M., Awais, Omar, Winger, Daniel G., Gibson, Michael K., Nason, Katie S.
Publié 2014Texte -
13
MUC2 Expression is an Adverse Prognostic Factor in Superficial Gastroesophageal Adenocarcinomas par Davison, Jon M., Ellis, Shane T., Foxwell, Tyler J., Luketich, James D., Gibson, Michael K., Kuan, Shih-Fan, Nason, Katie S.
Publié 2013Texte -
14
A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer par Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.
Publié 2010Texte -
15
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer par LaPelusa, Michael, Shen, Chan, Gillaspie, Erin A., Cann, Christopher, Lambright, Eric, Chakravarthy, A. Bapsi, Gibson, Michael K., Eng, Cathy
Publié 2022Texte -
16
The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults par Kennedy, Richard B., Simon, Whitney L., Gibson, Michael J., Goergen, Krista M., Grill, Diane E., Oberg, Ann L., Poland, Gregory A.
Publié 2016Texte -
17
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology par Haralambieva, Iana H., Gibson, Michael J., Kennedy, Richard B., Ovsyannikova, Inna G., Warner, Nathaniel D., Grill, Diane E., Poland, Gregory A.
Publié 2017Texte -
18
A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck par Yao, Min, Galanopoulos, Nicholas, Lavertu, Pierre, Fu, Pingfu, Gibson, Michael, Argiris, Athanassios, Rezaee, Rod, Zender, Chad, Wasman, Jay, Machtay, Mitchell, Savvides, Panos
Publié 2014Texte -
19
Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma par Yao, Min, Lavertu, Pierre, Savvides, Panayiotis, Woods, Charles, Fu, Pingfu, Gibson, Michael, Rezaee, Rod, Zender, Chad, Wasman, Jay, Sharma, Neelesh, Machtay, Mitchell
Publié 2016Texte -
20
Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma par Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
Publié 2018Texte